Stem Cell Research Enhancement Act Of 2007
Mr. Speaker, I rise in strong support of H.R. 3, the DeGette-Castle stem cell research bill. Our Nation's top scientists agree that embryonic stem cell research has the potential to unlock the doors to treatments and cures to numerous…
Mr. Speaker, I rise in strong support of H.R. 3, the DeGette-Castle stem cell research bill. Our Nation's top scientists agree that embryonic stem cell research has the potential to unlock the doors to treatments and cures to numerous diseases, including diabetes, Parkinson's disease, Alzheimer's, ALS, multiple sclerosis and cancer. Tens of millions of Americans and their families stand to benefit from this life-saving research.
Current policy allows Federal funds to be used for research only on those stem cell lines that existed when President Bush issued an executive order on August 9, 2001. However, few of the stem cell lines authorized by President Bush are now useful for research. According to the National Institutes of Health, of the 78 stem cell lines that were declared eligible for Federal funding in the President's executive order of August 2001, only about 22 lines are now still available for researchers; and, many of these 22 ``available'' stem cell lines are contaminated with ``mouse feeder'' cells, making their therapeutic use for humans uncertain.
H.R. 3 authorizes government support of research involving embryonic stem cells that
meet certain criteria, regardless of the date on which the stem cells were derived from an embryo. The bill creates an ethical framework for this research. It prohibits funding for research unless the cell lines were derived from excess embryos that were created for reproductive purposes and would otherwise be discarded. It also requires voluntary informed consent from the couples donating the excess embryos and prohibits any financial inducements.
H.R. 3 represents real hope to the tens of millions Americans suffering from devastating illnesses, and I encourage my colleagues to support it.